We are improving quality of life in the UK for an ageing population
The ageing population means that the average person can expect to live well into their seventies and beyond, but with this comes rising rates of cancer, heart disease and diabetes. Modern health care is under threat from the rise of drug-resistant infections, such as MRSA, salmonella and gonorrhoea, which can only be halted by more accurate diagnosis of infections, smarter use of existing drugs and the development of new ones.
Earlier diagnosis of diseases and peronalised treatment can improve the quality of life for patients, as well as increase the likelihood of complete recovery. Our imaging techniques are constantly improving the chances of tumour detection, and more focused beams are making treatment more effective with few side effects. Drug development is still expensive and painstaking, but our understanding of how the drug is acting means the chance of developing effective drugs can be increased.